Matches in Wikidata for { <http://www.wikidata.org/entity/Q74271361> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q74271361 description "assaig clínic" @default.
- Q74271361 description "clinical trial" @default.
- Q74271361 description "clinical trial" @default.
- Q74271361 description "clinical trial" @default.
- Q74271361 description "clinical trial" @default.
- Q74271361 description "ensaio clínico" @default.
- Q74271361 description "ensayo clínico" @default.
- Q74271361 description "ensayu clínicu" @default.
- Q74271361 description "essai clinique" @default.
- Q74271361 description "klinisch onderzoek" @default.
- Q74271361 description "клінічне випробування" @default.
- Q74271361 description "կլինիկական փորձարկում" @default.
- Q74271361 name "3-year Study in Dry Eye Disease Patients With Severe Keratitis Receiving Ikervis® (1mg/mL Ciclosporin)" @default.
- Q74271361 name "3-year Study in Dry Eye Disease Patients With Severe Keratitis Receiving Ikervis®" @default.
- Q74271361 type Item @default.
- Q74271361 label "3-year Study in Dry Eye Disease Patients With Severe Keratitis Receiving Ikervis® (1mg/mL Ciclosporin)" @default.
- Q74271361 label "3-year Study in Dry Eye Disease Patients With Severe Keratitis Receiving Ikervis®" @default.
- Q74271361 prefLabel "3-year Study in Dry Eye Disease Patients With Severe Keratitis Receiving Ikervis® (1mg/mL Ciclosporin)" @default.
- Q74271361 prefLabel "3-year Study in Dry Eye Disease Patients With Severe Keratitis Receiving Ikervis®" @default.
- Q74271361 P1050 Q74271361-93360789-74AF-4194-A657-029636731412 @default.
- Q74271361 P1050 Q74271361-D4E9347E-7869-4A83-ABAC-9659C850A1F2 @default.
- Q74271361 P1132 Q74271361-9E13E325-542B-467D-81D2-1210700E423B @default.
- Q74271361 P1476 Q74271361-4DCCE06C-7586-4323-91C4-45AF9D0851BF @default.
- Q74271361 P17 Q74271361-568D443E-AF99-49D9-A8BC-BD1B01638099 @default.
- Q74271361 P17 Q74271361-5A25DC19-A4B6-4743-8159-70C539D43C4B @default.
- Q74271361 P17 Q74271361-7341B94B-1346-4565-8E8D-5DACCA147E6A @default.
- Q74271361 P17 Q74271361-7C739280-66D7-4AEA-B61A-405464E22782 @default.
- Q74271361 P17 Q74271361-EB6D097D-5337-48A3-A85F-5E5C923AC2DA @default.
- Q74271361 P2899 Q74271361-514055B1-E000-4785-985A-9EFE042966CC @default.
- Q74271361 P3098 Q74271361-25D8DB1C-D4A8-46D2-B530-1000E35DCE02 @default.
- Q74271361 P31 Q74271361-FCD629AF-9F38-4AA9-BFDD-E11BB28B19FC @default.
- Q74271361 P580 Q74271361-B092F555-5BC5-43EA-80A3-4FD3F0C77E5D @default.
- Q74271361 P582 Q74271361-C92C3063-4598-4CC2-AEC8-C9FD70125981 @default.
- Q74271361 P6099 Q74271361-04AF83AB-2893-46FB-AD12-0C05174AF6A8 @default.
- Q74271361 P8363 Q74271361-2A598FE0-A7A5-481C-A120-7BD8C5A5FA76 @default.
- Q74271361 P1050 Q1162694 @default.
- Q74271361 P1050 Q757838 @default.
- Q74271361 P1132 "+350" @default.
- Q74271361 P1476 "A Phase IIIb, Prospective, Interventional, Multicentre, 3-year Study to Explore the Long-term Evolution of Sign and Symptoms, and Occurence of Complications in Dry Eye Patients With Severe Keratitis Receiving Ikervis® (1mg/mL Ciclosporin)" @default.
- Q74271361 P17 Q142 @default.
- Q74271361 P17 Q29 @default.
- Q74271361 P17 Q36 @default.
- Q74271361 P17 Q38 @default.
- Q74271361 P17 Q43 @default.
- Q74271361 P2899 "+18" @default.
- Q74271361 P3098 "NCT04144413" @default.
- Q74271361 P31 Q30612 @default.
- Q74271361 P580 "2019-05-31T00:00:00Z" @default.
- Q74271361 P582 "2023-05-31T00:00:00Z" @default.
- Q74271361 P6099 Q42824827 @default.
- Q74271361 P8363 Q78089383 @default.